| scholarly article | Q13442814 |
| P50 | author | Gyeong Hoon Kang | Q56613348 |
| P2093 | author name string | Jeong Mo Bae | |
| Nam-Yun Cho | |||
| Seung-Yeon Yoo | |||
| Ji-Ae Lee | |||
| Yunjoo Shin | |||
| P2860 | cites work | QuPath: Open source software for digital pathology image analysis | Q47108040 |
| The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma | Q47620321 | ||
| Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers. | Q50591311 | ||
| Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4. | Q51780933 | ||
| Smad4 and epithelial-mesenchymal transition proteins in colorectal carcinoma: an immunohistochemical study. | Q52375024 | ||
| Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. | Q52551767 | ||
| The role of TGF-β/SMAD4 signaling in cancer. | Q52688883 | ||
| High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis. | Q53215560 | ||
| Expression of Smad4 and TGF-beta2 in colorectal carcinoma. | Q53343351 | ||
| Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2. | Q53595935 | ||
| Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. | Q54913216 | ||
| SMAD4 as a Prognostic Marker in Colorectal Cancer | Q57567752 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma | Q79748370 | ||
| SMAD4 protein expression and cell proliferation in colorectal adenocarcinomas | Q82045783 | ||
| Smad4 may help to identify a subset of colorectal cancer patients with early recurrence after curative therapy | Q82176570 | ||
| Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer | Q82948307 | ||
| SMAD4/DPC4 expression and prognosis in human colorectal cancer | Q83890294 | ||
| Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers | Q87468260 | ||
| SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance | Q90764264 | ||
| SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer | Q91014088 | ||
| The epithelial-mesenchymal transition (EMT) phenomenon | Q24600898 | ||
| SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer | Q27824786 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| DPC4/SMAD4 gene alterations in human cancer, and their functional implications | Q33178748 | ||
| TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study | Q33293871 | ||
| Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system | Q33577619 | ||
| Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers | Q34344060 | ||
| A review of juvenile polyposis syndrome | Q34562065 | ||
| Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients | Q35045711 | ||
| Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression | Q35065708 | ||
| A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer | Q35150637 | ||
| The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC. | Q35677720 | ||
| High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer. | Q35919299 | ||
| Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway | Q37594355 | ||
| Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis | Q37725506 | ||
| Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma. | Q38407335 | ||
| Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis | Q38837709 | ||
| Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer | Q38988997 | ||
| Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis | Q39119552 | ||
| Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines. | Q39979522 | ||
| Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer. | Q40009622 | ||
| Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta. | Q40076480 | ||
| The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells | Q40314308 | ||
| Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes. | Q40497351 | ||
| Frequent loss of SMAD4/DPC4 protein in colorectal cancers | Q43006283 | ||
| Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis. | Q44029017 | ||
| Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group | Q45273769 | ||
| Evaluation of the prognostic value of pSMAD immunohistochemistry in colorectal cancer. | Q46032894 | ||
| Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer | Q46676671 | ||
| SMAD4 levels and response to 5-fluorouracil in colorectal cancer | Q46689448 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| P304 | page(s) | 289-297 | |
| P577 | publication date | 2019-06-24 | |
| P1433 | published in | Journal of pathology and translational medicine | Q27726237 |
| P1476 | title | Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma | |
| P478 | volume | 53 |
Search more.